The nausea conundrum Professor Trapp also investigates the side effects associated with current GLP-1 receptor agonists, particularly nausea
Medical writing support, under the direction of the authors, was provided by Eric Comeau, Ph.D., of CMC Connect, McCann Health Medical Communications and was funded by Pfizer Inc., New York, NY, USA, in accordance with Good Publication Practice (GPP3) guidelines (Ann Intern Med 2015;163:461464).
Zhang Y, Qu Z, Lu T, Shao X, Cai M, Dilimulati D, et al
Chemical structure of semaglutide and liraglutide and its interaction with GLP-1 receptor One of the pharmacological approaches against diseases like diabetes and obesity involves prolonging the time of action of GLP-1